246 related articles for article (PubMed ID: 17593238)
1. Diabetic neuropathy: new strategies for treatment.
Várkonyi T; Kempler P
Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of neuropathies].
Kempler P
Orv Hetil; 2010 Jan; 151(2):62-5. PubMed ID: 20061234
[No Abstract] [Full Text] [Related]
4. Clinical inquiry: what medications are best for diabetic neuropathic pain?
Page N; Deluca J; Crowell K
J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
[TBL] [Abstract][Full Text] [Related]
5. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
6. Advances in the management of diabetic neuropathy.
Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Terneus W
J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
[TBL] [Abstract][Full Text] [Related]
8. Career lifetime advances and key developments: diabetes.
Baglioni P; Govindan J; Khan A
Clin Med (Lond); 2007 Jun; 7(3):303-4. PubMed ID: 17639617
[No Abstract] [Full Text] [Related]
9. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
Ziegler D; Schneider E; Boess FG; Berggren L; Birklein F
J Diabetes Complications; 2014; 28(5):698-704. PubMed ID: 24862108
[TBL] [Abstract][Full Text] [Related]
10. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
[TBL] [Abstract][Full Text] [Related]
15. Drugs for neuropathic pain.
Kalso E; Aldington DJ; Moore RA
BMJ; 2013 Dec; 347():f7339. PubMed ID: 24355386
[No Abstract] [Full Text] [Related]
16. [Evidence-based pharmacotherapy of neuropathic pain syndromes].
Braune S
MMW Fortschr Med; 2004 Dec; 146(50):49-51. PubMed ID: 15658522
[TBL] [Abstract][Full Text] [Related]
17. [Symptomatic treatment of painful diabetic neuropathy].
Maeda K; Yasuda H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():609-13. PubMed ID: 15999779
[No Abstract] [Full Text] [Related]
18. Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
Happich M; Schneider E; Boess FG; Wilhelm S; Schacht A; Birklein F; Ziegler D
Clin J Pain; 2014 Oct; 30(10):875-85. PubMed ID: 24296910
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
20. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
Bellows BK; Dahal A; Jiao T; Biskupiak J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]